Clinical Trials | April 22, 2026
Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease
By cutting pain crises & boosting haemoglobin
By cutting pain crises & boosting haemoglobin
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
Subscribe To Our Newsletter & Stay Updated
